Artificial, a Palo Alto-based startup, just announced a $21.5M funding round, including investment from M12, Microsoft’s venture fund, to further develop and commercialize its lab automation software.

Most people still picture science as a person in a white coat, pipette in hand. That image is stubbornly accurate. Even in 2025—after decades of lab robots, high‑throughput screening, and cloud ...

Automation can offer labs a vast range of benefits, from improving productivity and accuracy to enabling researchers to focus on less menial tasks. Despite this potential, many labs are hesitant to ...

News-Medical speaks to David Dambman from Biosero about the emerging importance of automation in scientific research and how a centralized scheduling software is an essential first step for any ...

SAN DIEGO--(BUSINESS WIRE)--Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that it has joined the Genedata Ready-to-Run program, ...

Bruker Corporation BRKR recently introduced the SciY platform of advanced scientific and automation software solutions. The vendor-agnostic advanced platform offers a broad range of software solutions ...

Dublin, Feb. 22, 2018 (GLOBE NEWSWIRE) -- The "Global Laboratory Automation Systems Market - Analysis and Forecast (2017-2026) (Focus on Product, Application, End User, Market Share Analysis, 15 ...

REDDING, Calif., May 13, 2024 /PRNewswire/ -- According to a new market research report titled, 'Clinical Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, ...

SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Biosero, Inc. announced a new partnership wherein RORZE Lifescience, Inc., a subsidiary of Rorze, Inc. (TYO: 6323), will commercialize Biosero's Green Button ...